RITUXIMAB PLUS HYPERCVAD ALTERNATING WITH HIGH DOSE METHOTREXATE AND CYTARABINE (R-HCVAD-AM) FOR PATIENTS WITH NEWLY DIAGNOSED MANTLE CELL LYMPHOMA (MCL). A MULTICENTER TRIAL FROM GISL
2011
Keywords:
- Correction
- Cite
- Save
- Machine Reading By IdeaReader
0
References
3
Citations
NaN
KQI